Decreased levels of serum platelet-activating factor acetylhydrolase in patients with rheumatic diseases
PAF is a potent inflammatory compound known to stimulate the release of various cytokines involved in rheumatic diseases. Elevated blood PAF levels are reported in these patients. We report that serum PAF acetylhydrolase activity (AHA) levels are decreased in patients with rheumatoid arthritis or os...
Saved in:
Main Authors: | P. Vergne (Author), V. Praloran (Author), R. Treves (Author), Y. Denizot (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
1997-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Platelet-activating factor acetylhydrolase and haemophagocytosis in the sepsis syndrome
by: Franck Trimoreau, et al.
Published: (2000) -
Elevated plasma phospholipase A2 and platelet-activating factor acetylhydrolase activity in colorectal cancer
by: Yves Denizot, et al.
Published: (2004) -
Effect of platelet-activating factor on the growth of human erythroid and myeloid CD34+ progenitors
by: F. Dupuis, et al.
Published: (1998) -
PAF and Haematopoiesis. I. 5-Fluoro-Uracil Induces PAF Production in Haematopoietic Organs of Rats
by: Y. Denizot, et al.
Published: (1994) -
Molecular Model of Plasma PAF Acetylhydrolase-Lipoprotein Association: Insights from the Structure
by: Brian J. Bahnson, et al.
Published: (2010)